VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has officially announced the winners of the Ophthalmology Star Awards 2025 (OSA). The awards were revealed following VSY Biotechnology GmbH’s Booth Talk event at the ESCRS 2025 Congress in Copenhagen.

Honoring Excellence in Ophthalmic Research
The annual Ophthalmology Star Awards recognize outstanding contributions to the field of ophthalmology. The ceremony highlights individuals whose clinical and scientific advancements have significantly improved the understanding, diagnosis, and treatment of eye diseases.

This year’s winning entries reflect innovative research in drug delivery systems, corneal surgery, and viscoelastic materials, each with potential to shape the future of ophthalmic care. 

Here are the winners of the 2025 Ophthalmology Star Awards:

First Place, Gema Martinez Navarrete – Spain
Dr. Gema Martinez Navarrete received first place for her study titled "A novel bevacizumab delivery system using solid lipid nanoparticles for potential wet age-related macular degeneration treatment: An in vivo study." As she was unable to attend the ESCRS Congress in person, the prize was sent to her directly.

Second Place, Ahmet Kırgız – Türkiye

Ahmet Kırgız received second place for his study titled "Clinical outcomes of femtosecond laser-assisted corneal allogenic intrastromal ring segment (CAIRS) in the treatment of keratoconus." The award was presented by Dr. Lena Beckers during the VSY Booth Talk, where she also delivered a presentation titled “From Standard to Standout: Starting with Premium Care.”

Third Place, David Lockington – United Kingdom

David Lockington from the United Kingdom received third place for his study titled "Impact of temperature on ophthalmic viscosurgical devices and clinical implications: a pilot study." The award was presented by Dr. Christian Bach, Managing Director of VSY Biotechnology GmbH.

Supporting Innovation and Scientific Progress
The 2025 award recipients demonstrated outstanding commitment and innovation in their respective areas of ophthalmic research. Their work is expected to influence future clinical practices and improve patient outcomes on a global scale.

VSY Biotechnology GmbH remains committed to advancing ophthalmic science and technology. Through the Ophthalmology Star Awards, the company reinforces its support for researchers driving innovation and contributing to the future of eye care.